Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
Author:
Affiliation:
1. Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
2. Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea.
Funder
Korean Society of Pediatric Hematology-Oncology
Publisher
Korean Pediatric Society
Subject
Pediatrics,Pediatrics, Perinatology, and Child Health
Link
https://synapse.koreamed.org/pdf/10.3345/kjp.2018.61.2.53
Reference19 articles.
1. Pediatric Solid Malignancies: Neuroblastoma and Wilms' Tumor
2. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors
3. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
4. Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by MYCN Status and Tumor Cell Ploidy
5. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genomic ALK alterations in primary and relapsed neuroblastoma;British Journal of Cancer;2023-02-17
2. A Survey on Publicly Available Open Datasets Derived From Electronic Health Records (EHRs) of Patients with Neuroblastoma;Data Science Journal;2022-10-04
3. Innovative therapies for neuroblastoma: The surprisingly potent role of iron chelation in up-regulating metastasis and tumor suppressors and down-regulating the key oncogene, N-myc;Pharmacological Research;2021-11
4. Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplification;Pediatric Blood & Cancer;2021-04-07
5. Survival patterns of childhood neuroblastoma;European Journal of Cancer Prevention;2020-09-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3